Literature DB >> 11567967

Uveal tumour resection.

D H Char1, T Miller, J B Crawford.   

Abstract

AIM: To review the ocular retention rates, visual results, and metastases in uveal tumours managed with eye wall resection techniques.
METHODS: This was a retrospective analysis of consecutive local uveal tumour resections performed by a single surgeon. All enucleation specimens were reviewed by one author. Both parametric and non-parametric analysis of data were performed.
RESULTS: 138 eyes were scheduled for eye wall resection surgery. The mean age was 52 years (range 11-86 years). Tumours involved predominantly the iris in 14 cases, iris-ciliary body in 57, ciliary body alone in 18 patients, and in 49 cases the choroid was involved (ciliochoroidal, iris-ciliary body-choroid, or choroid). 125 eyes harboured melanomas; posterior tumours were more likely to have epithelioid cells (p<0.05). The mean follow up was 6 years. The mean clock hours in iris and iris-ciliary body tumours was 3.5. In tumours that involved the choroid the mean largest diameter was 12.9 mm and the mean thickness 8.5 mm. 105 of 138 (76%) eyes were retained. Histological assessment of surgical margins did not correlate evidence of tumour in enucleated eyes or metastatic disease. Surgical margins of more anterior tumours were more likely to be clear on histological evaluation (p<0.05). Approximately 53% of retained eyes had a final visual acuity of > or =20/40; visual results were significantly better in more anteriorly located tumours (p<0.05). All retained iris tumour cases had > or =20/40 final visual acuity. In tumours that involved the choroid nine of 31 retained eyes kept that level of visual acuity. Eight patients developed metastases; all metastatic events developed in patients with tumours that involved the choroid, and seven of eight were mixed cell melanomas.
CONCLUSIONS: 76% of eyes were retained and 53% of these had a final visual acuity of > or =20/40. Only 7% of uveal melanoma patients developed metastatic disease with a mean follow up of 6 years. Survival did not appear to be compromised with eye wall resection and in very thick, more posterior melanomas it appeared that ocular retention and visual results were better than with radiation alone.

Entities:  

Mesh:

Year:  2001        PMID: 11567967      PMCID: PMC1723717          DOI: 10.1136/bjo.85.10.1213

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  33 in total

1.  PARTIAL CYCLECTOMY. SOME FURTHER MODIFICATIONS IN TECHIQUE.

Authors:  H B STALLARD
Journal:  Br J Ophthalmol       Date:  1964-01       Impact factor: 4.638

2.  MALIGNANT MELANOMA OF THE IRIS AND CILIARY BODY: SURGICAL EXCISION.

Authors:  G W CLEASBY
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1963 Sep-Oct

3.  Posterior lamellar resection of the cornea for epithelial implantation cyst in the anterior chamber.

Authors:  H S SUGAR; A L WILLENZ
Journal:  Am J Ophthalmol       Date:  1962-11       Impact factor: 5.258

4.  Risk factors for residual and recurrent uveal melanoma after trans-scleral local resection.

Authors:  B E Damato; J Paul; W S Foulds
Journal:  Br J Ophthalmol       Date:  1996-02       Impact factor: 4.638

5.  Iridocyclectomy. A technique for removal of iris nelanomas.

Authors:  W E Borley; W W Miller
Journal:  Am J Ophthalmol       Date:  1965-11       Impact factor: 5.258

6.  Ten-year follow-up of helium ion therapy for uveal melanoma.

Authors:  D H Char; S M Kroll; J Castro
Journal:  Am J Ophthalmol       Date:  1998-01       Impact factor: 5.258

7.  Block excision of tumors of the anterior uvea. Report on 68 consecutive patients.

Authors:  G O Naumann; V Rummelt
Journal:  Ophthalmology       Date:  1996-12       Impact factor: 12.079

8.  Microscopic examination of surgical margins of intraocular tumors excised en bloc.

Authors:  C E Margo
Journal:  Ophthalmic Surg Lasers       Date:  1998-08

9.  Risk factors for metastatic uveal melanoma after trans-scleral local resection.

Authors:  B E Damato; J Paul; W S Foulds
Journal:  Br J Ophthalmol       Date:  1996-02       Impact factor: 4.638

10.  Internal resection of posterior uveal melanomas.

Authors:  P J Kertes; J C Johnson; G A Peyman
Journal:  Br J Ophthalmol       Date:  1998-10       Impact factor: 4.638

View more
  13 in total

1.  [Malignant melanoma of the uvea. Current status and prospects].

Authors:  N Bornfeld
Journal:  Ophthalmologe       Date:  2002-05       Impact factor: 1.059

2.  Recurrent choroidal melanoma after transscleral local resection with diffuse vitreous seeding.

Authors:  Pedro Gonzalez; Ewan G Kemp; Fiona Roberts
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-02-03       Impact factor: 3.117

3.  Secondary endoresection for previously treated choroidal melanomas with a non-responsive course and persistent exudative retinal detachment.

Authors:  Ahmet Kaan Gündüz; Ibadulla Mirzayev
Journal:  Int J Ophthalmol       Date:  2022-02-18       Impact factor: 1.779

4.  Diffuse iris melanoma: Report of a case with review of the literature.

Authors:  Simon E Skalicky; Michael Giblin; R Max Conway
Journal:  Clin Ophthalmol       Date:  2007-09

5.  Exoresection via partial lamellar sclerouvectomy approach for uveal tumors: A successful performance by a novice surgeon.

Authors:  Rengin Aslihan Kurt; Kaan Gündüz
Journal:  Clin Ophthalmol       Date:  2010-02-02

6.  Exoresection and endoresection for uveal melanoma.

Authors:  Kaan Gündüz; Nikolaos E Bechrakis
Journal:  Middle East Afr J Ophthalmol       Date:  2010-07

Review 7.  Partial lamellar sclerouvectomy surgery for anteriorly located uveal tumour resection: a 20-year experience.

Authors:  Ibadulla Mirzayev; Ahmet Kaan Gündüz; Aylin Okçu Heper
Journal:  Eye (Lond)       Date:  2021-05-03       Impact factor: 4.456

8.  Eye wall resections for intraocular tumors: our experience.

Authors:  Tandava Krishnan; Lingam Gopal; Jyotirmay Biswas; Prema Padmanabhan; Vikas Khetan
Journal:  Indian J Ophthalmol       Date:  2014-04       Impact factor: 1.848

9.  Outcomes of primary endoresection for choroidal melanoma.

Authors:  Andre A C Vidoris; Andre Maia; Marcia Lowen; Melina Morales; Jordan Isenberg; Bruno F Fernandes; Rubens N Belfort
Journal:  Int J Retina Vitreous       Date:  2017-11-06

10.  Clinicopathologic correlations in eyes enucleated after uveal melanoma resection with positive surgical margins.

Authors:  Yousuf Khalifa; Thomas M Aaberg; Thomas M Aaberg; Hans E Grossniklaus
Journal:  Indian J Ophthalmol       Date:  2007 Sep-Oct       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.